Related Experiment Video
Updated: Jan 15, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Leprosy in India: challenges, advances and the path to eradication
Sayanti Chatterjee1, Pragya Santra1, Riddhi Paul1
1Amity Institute of Biotechnology, Amity University Kolkata, Action area II, Rajarhat Newtown, Kolkata 700135 West Bengal, India.
India aims for zero leprosy transmission by 2027, tackling high prevalence pockets and unknown transmission chains. This review covers the disease
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- Leprosy elimination efforts in India are in a critical final phase.
- High prevalence pockets and unmapped transmission chains persist.
- Understanding leprosy's multifaceted nature is crucial for eradication.
Purpose of the Study:
- To provide a foundational understanding of leprosy.
- To consolidate knowledge on the causative agent, prognosis, epidemiology, societal impacts, and prevention.
- To stimulate innovative research for leprosy control.
Main Methods:
- Literature review and synthesis of existing data on leprosy.
- Analysis of epidemiological trends and transmission dynamics.
- Examination of societal factors influencing disease spread and management.
Main Results:
- Leprosy remains a public health challenge in specific Indian regions.
- Understanding transmission chains is key to targeted interventions.
- Societal stigma and awareness significantly impact prevention and treatment adherence.
Conclusions:
- Achieving zero leprosy transmission by 2027 requires a comprehensive, multi-pronged strategy.
- Continued research and innovation are vital for overcoming remaining obstacles.
- Integrated approaches addressing biological, social, and epidemiological aspects are essential for leprosy eradication.
More Related Videos
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
09:39DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA
Published on: July 15, 2011
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...